SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
John Hancock Fds III Disciplined Value Mid Cap Fd Cl A (JVMAX) trades at a trailing P/E of 62.0. Trailing earnings yield is 1.61%.
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 62.0).
- Trailing Earnings Yield 1.61% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
Overall SharesGrow Score: 61/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — JVMAX
Valuation Multiples
P/E (TTM)62.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio22.32
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.44
Book Value / Share$0.00
Revenue / Share$1.22
FCF / Share$0.00
Yields & Fair Value
Earnings Yield1.61%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$3.37 |
$14.54M |
$62.48M |
429.7% |
| 2015 |
$3.27 |
$19.85M |
$60.67M |
305.6% |
| 2016 |
$10.28 |
$18.29M |
$191.42M |
1046.6% |
| 2017 |
$3.43 |
$18.37M |
$64.09M |
348.8% |
| 2018 |
$-6.21 |
$20.21M |
$-115.97M |
-573.9% |
| 2019 |
$9.51 |
$22.36M |
$177.85M |
795.4% |
| 2020 |
$-5.65 |
$20.29M |
$-106.02M |
-522.5% |
| 2021 |
$13.36 |
$21.3M |
$254.02M |
1192.8% |
| 2022 |
$-4.51 |
$22.85M |
$-86.92M |
-380.4% |
| 2023 |
$0.44 |
$24.05M |
$8.64M |
35.9% |
